Omega Healthcare Investors (NYSE:OHI) Releases Quarterly Earnings Results, Beats Expectations By $0.32 EPS

Omega Healthcare Investors (NYSE:OHI) posted its quarterly earnings results on Wednesday. The real estate investment trust reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.32, Zacks reports. The business had revenue of $328.25 million during the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. Omega Healthcare Investors’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.77 earnings per share. Omega Healthcare Investors updated its FY 2026 guidance to 3.220-3.260 EPS.

Omega Healthcare Investors Stock Down 0.6%

Omega Healthcare Investors stock traded down $0.32 during midday trading on Wednesday, reaching $51.32. The stock had a trading volume of 2,450,546 shares, compared to its average volume of 1,690,623. The stock has a market capitalization of $15.28 billion, a P/E ratio of 24.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.58. The firm’s fifty day simple moving average is $47.65 and its 200-day simple moving average is $46.59. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. Omega Healthcare Investors has a 1-year low of $38.59 and a 1-year high of $52.07.

Omega Healthcare Investors Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, August 3rd will be given a $0.68 dividend. The ex-dividend date of this dividend is Monday, August 3rd. This represents a $2.72 dividend on an annualized basis and a yield of 5.3%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s payout ratio is 129.47%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on OHI shares. Citigroup reiterated a “market perform” rating on shares of Omega Healthcare Investors in a report on Monday, June 15th. Truist Financial lowered their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating for the company in a research report on Tuesday, June 9th. Scotiabank reduced their target price on Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Raymond James Financial assumed coverage on Omega Healthcare Investors in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 target price for the company. Finally, Bank of America restated an “underperform” rating and issued a $46.00 price target (down from $52.00) on shares of Omega Healthcare Investors in a report on Tuesday, April 14th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $48.50.

Institutional Trading of Omega Healthcare Investors

A number of hedge funds and other institutional investors have recently made changes to their positions in OHI. GeoWealth Management LLC boosted its holdings in Omega Healthcare Investors by 1.3% during the third quarter. GeoWealth Management LLC now owns 18,850 shares of the real estate investment trust’s stock worth $796,000 after purchasing an additional 239 shares during the last quarter. EntryPoint Capital LLC grew its position in Omega Healthcare Investors by 2.7% in the fourth quarter. EntryPoint Capital LLC now owns 9,912 shares of the real estate investment trust’s stock valued at $439,000 after purchasing an additional 260 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in Omega Healthcare Investors by 40.9% in the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after buying an additional 268 shares during the last quarter. Guggenheim Capital LLC increased its stake in Omega Healthcare Investors by 1.0% in the 2nd quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock valued at $1,077,000 after buying an additional 280 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its position in Omega Healthcare Investors by 1.7% during the 4th quarter. Quadrant Capital Group LLC now owns 18,351 shares of the real estate investment trust’s stock worth $814,000 after buying an additional 304 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.